Challenges and Advances in the Simulation of Targeted Covalent Inhibitors Using Quantum Computing

Area of Science:

• Computational chemistry
• Drug discovery
• Quantum computing

Background:

• Targeted covalent inhibitors (TCIs) are a promising drug class forming specific chemical bonds with biological targets.
• Understanding the mechanism and environmental influence on TCI reactivity is crucial but challenging.
• Accurate simulation of protein-ligand interactions for TCIs is a significant hurdle in drug design.

Purpose of the Study:

• To explore the potential of quantum computing in advancing the design of targeted covalent inhibitors.
• To discuss how quantum computing can provide mechanistic insights into covalent bond formation.
• To highlight the role of quantum computing in accelerating de novo drug discovery.

Main Methods:

• Leveraging advances in quantum computing hardware and algorithms.
• High-level quantum chemical simulations.
• Modeling protein-ligand interactions.

Main Results:

• Quantum computing can provide detailed mechanistic insights into covalent bond formation in TCIs.
• Enhanced accuracy in simulating protein-ligand interactions for TCIs.
• Potential to accelerate the de novo drug discovery process for TCIs.

Conclusions:

• Quantum computing holds significant promise for overcoming current challenges in TCI design.
• Accurate simulations via quantum computing can lead to more effective and specific covalent inhibitor drugs.
• This approach is expected to accelerate the development of novel therapeutics.